chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram head normal, Cough, Delirium, Dyspnoea, Electrocardiogram
Clinical narrative: COVId Vaccine Breakthrough Case  Moderna Dose 1 3/9/21 (036A21A) Moderna Dose 2 4/5/21 (016B21A) Moderna Dose 3 12/8/21 (939909) COVID Positive 12/15/21  12/15/21: -Patient is a 95 yo male from Nursing home with medical history of atrial fibrillation on anticoagulation , CKD stage 3, DMT2 with peripheral neuropathy , GERD, HTN, HLD, hypothyroidism , Dementia  -He was brought to the ER primarily because of bradycardia which is now resolved  -He also had cough and SOB and tested positive for COVID  -Patient is a poor historian because of underlying dementia  -His vitals on arrival no fever, HR 60s, RR 20s, BP 157/66 maintaining oxygen saturating on room air  -Lab remarkable for AKI Cr 1.28, elevated proBNP 7K, ALP 122, trop elevation 0.05 x 2, VBG ( PH 7.32, pCO2 55, pO2 35) , CBC unremarkable, urinalysis unremarkable, INR 2.0 influenza negative . EKG showed ventricular paced rhythm. Blood culture sent.  -CXR showed increased streaky opacity in right lung base could represent atelectasis versus infiltrate.  -Patient received Duoneb Tx , IV Ceftriaxone and Azithromycin IV lasix 40mg in the ER  -During encounter was impulsive, appears to be sundowning  12/20/21:  95-year-old male resident of a nursing home with dementia, atrial fibrillation anticoagulated on warfarin, permanent pacemaker, type 2 diabetes mellitus, hypertension presented with cough, shortness of breath and bradycardia.  Patient admitted for COVID-19 with superimposed bacterial pneumonia, sinus bradycardia which has resolved on arrival to the hospital.  Patient treated with antibiotics, IV dexamethasone and breathing treatments.  Due to his bradycardia remdesivir was not given.  Patient was briefly on oxygen subsequently weaned off to room air , shortness of breath and cough has improved.  Had an episode of a fall during the hospitalization with no sequelae, head CT was unremarkable for acute abnormalities.  Patient has supratherapeutic INR with no evidence of bleeding, was given vitamin K 2.5 mg p.o. x1 and warfarin was held on discharge.  INR will be checked in 2 days of discharge to be followed by patient's primary care provider.  PTOT evaluated patient and recommended returning to assisted living with VNA.  On discharge patient was a febrile and hemodynamically stable.  Patient the will be on Medrol Dosepak.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Full blood count normal, Impulsive behaviour, Inappropriate schedule of product administration, Influenza virus test negative
Clinical narrative: COVId Vaccine Breakthrough Case  Moderna Dose 1 3/9/21 (036A21A) Moderna Dose 2 4/5/21 (016B21A) Moderna Dose 3 12/8/21 (939909) COVID Positive 12/15/21  12/15/21: -Patient is a 95 yo male from Nursing home with medical history of atrial fibrillation on anticoagulation , CKD stage 3, DMT2 with peripheral neuropathy , GERD, HTN, HLD, hypothyroidism , Dementia  -He was brought to the ER primarily because of bradycardia which is now resolved  -He also had cough and SOB and tested positive for COVID  -Patient is a poor historian because of underlying dementia  -His vitals on arrival no fever, HR 60s, RR 20s, BP 157/66 maintaining oxygen saturating on room air  -Lab remarkable for AKI Cr 1.28, elevated proBNP 7K, ALP 122, trop elevation 0.05 x 2, VBG ( PH 7.32, pCO2 55, pO2 35) , CBC unremarkable, urinalysis unremarkable, INR 2.0 influenza negative . EKG showed ventricular paced rhythm. Blood culture sent.  -CXR showed increased streaky opacity in right lung base could represent atelectasis versus infiltrate.  -Patient received Duoneb Tx , IV Ceftriaxone and Azithromycin IV lasix 40mg in the ER  -During encounter was impulsive, appears to be sundowning  12/20/21:  95-year-old male resident of a nursing home with dementia, atrial fibrillation anticoagulated on warfarin, permanent pacemaker, type 2 diabetes mellitus, hypertension presented with cough, shortness of breath and bradycardia.  Patient admitted for COVID-19 with superimposed bacterial pneumonia, sinus bradycardia which has resolved on arrival to the hospital.  Patient treated with antibiotics, IV dexamethasone and breathing treatments.  Due to his bradycardia remdesivir was not given.  Patient was briefly on oxygen subsequently weaned off to room air , shortness of breath and cough has improved.  Had an episode of a fall during the hospitalization with no sequelae, head CT was unremarkable for acute abnormalities.  Patient has supratherapeutic INR with no evidence of bleeding, was given vitamin K 2.5 mg p.o. x1 and warfarin was held on discharge.  INR will be checked in 2 days of discharge to be followed by patient's primary care provider.  PTOT evaluated patient and recommended returning to assisted living with VNA.  On discharge patient was a febrile and hemodynamically stable.  Patient the will be on Medrol Dosepak.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: International normalised ratio increased, Laboratory test abnormal, Lung opacity, PCO2 increased, PO2 decreased
Clinical narrative: COVId Vaccine Breakthrough Case  Moderna Dose 1 3/9/21 (036A21A) Moderna Dose 2 4/5/21 (016B21A) Moderna Dose 3 12/8/21 (939909) COVID Positive 12/15/21  12/15/21: -Patient is a 95 yo male from Nursing home with medical history of atrial fibrillation on anticoagulation , CKD stage 3, DMT2 with peripheral neuropathy , GERD, HTN, HLD, hypothyroidism , Dementia  -He was brought to the ER primarily because of bradycardia which is now resolved  -He also had cough and SOB and tested positive for COVID  -Patient is a poor historian because of underlying dementia  -His vitals on arrival no fever, HR 60s, RR 20s, BP 157/66 maintaining oxygen saturating on room air  -Lab remarkable for AKI Cr 1.28, elevated proBNP 7K, ALP 122, trop elevation 0.05 x 2, VBG ( PH 7.32, pCO2 55, pO2 35) , CBC unremarkable, urinalysis unremarkable, INR 2.0 influenza negative . EKG showed ventricular paced rhythm. Blood culture sent.  -CXR showed increased streaky opacity in right lung base could represent atelectasis versus infiltrate.  -Patient received Duoneb Tx , IV Ceftriaxone and Azithromycin IV lasix 40mg in the ER  -During encounter was impulsive, appears to be sundowning  12/20/21:  95-year-old male resident of a nursing home with dementia, atrial fibrillation anticoagulated on warfarin, permanent pacemaker, type 2 diabetes mellitus, hypertension presented with cough, shortness of breath and bradycardia.  Patient admitted for COVID-19 with superimposed bacterial pneumonia, sinus bradycardia which has resolved on arrival to the hospital.  Patient treated with antibiotics, IV dexamethasone and breathing treatments.  Due to his bradycardia remdesivir was not given.  Patient was briefly on oxygen subsequently weaned off to room air , shortness of breath and cough has improved.  Had an episode of a fall during the hospitalization with no sequelae, head CT was unremarkable for acute abnormalities.  Patient has supratherapeutic INR with no evidence of bleeding, was given vitamin K 2.5 mg p.o. x1 and warfarin was held on discharge.  INR will be checked in 2 days of discharge to be followed by patient's primary care provider.  PTOT evaluated patient and recommended returning to assisted living with VNA.  On discharge patient was a febrile and hemodynamically stable.  Patient the will be on Medrol Dosepak.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Pacemaker generated rhythm, Pneumonia bacterial, Prohormone brain natriuretic peptide increased, SARS-CoV-2 test positive, Sinus bradycardia
Clinical narrative: COVId Vaccine Breakthrough Case  Moderna Dose 1 3/9/21 (036A21A) Moderna Dose 2 4/5/21 (016B21A) Moderna Dose 3 12/8/21 (939909) COVID Positive 12/15/21  12/15/21: -Patient is a 95 yo male from Nursing home with medical history of atrial fibrillation on anticoagulation , CKD stage 3, DMT2 with peripheral neuropathy , GERD, HTN, HLD, hypothyroidism , Dementia  -He was brought to the ER primarily because of bradycardia which is now resolved  -He also had cough and SOB and tested positive for COVID  -Patient is a poor historian because of underlying dementia  -His vitals on arrival no fever, HR 60s, RR 20s, BP 157/66 maintaining oxygen saturating on room air  -Lab remarkable for AKI Cr 1.28, elevated proBNP 7K, ALP 122, trop elevation 0.05 x 2, VBG ( PH 7.32, pCO2 55, pO2 35) , CBC unremarkable, urinalysis unremarkable, INR 2.0 influenza negative . EKG showed ventricular paced rhythm. Blood culture sent.  -CXR showed increased streaky opacity in right lung base could represent atelectasis versus infiltrate.  -Patient received Duoneb Tx , IV Ceftriaxone and Azithromycin IV lasix 40mg in the ER  -During encounter was impulsive, appears to be sundowning  12/20/21:  95-year-old male resident of a nursing home with dementia, atrial fibrillation anticoagulated on warfarin, permanent pacemaker, type 2 diabetes mellitus, hypertension presented with cough, shortness of breath and bradycardia.  Patient admitted for COVID-19 with superimposed bacterial pneumonia, sinus bradycardia which has resolved on arrival to the hospital.  Patient treated with antibiotics, IV dexamethasone and breathing treatments.  Due to his bradycardia remdesivir was not given.  Patient was briefly on oxygen subsequently weaned off to room air , shortness of breath and cough has improved.  Had an episode of a fall during the hospitalization with no sequelae, head CT was unremarkable for acute abnormalities.  Patient has supratherapeutic INR with no evidence of bleeding, was given vitamin K 2.5 mg p.o. x1 and warfarin was held on discharge.  INR will be checked in 2 days of discharge to be followed by patient's primary care provider.  PTOT evaluated patient and recommended returning to assisted living with VNA.  On discharge patient was a febrile and hemodynamically stable.  Patient the will be on Medrol Dosepak.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Superinfection, Troponin increased, Urine analysis normal, Vaccine breakthrough infection
Clinical narrative: COVId Vaccine Breakthrough Case  Moderna Dose 1 3/9/21 (036A21A) Moderna Dose 2 4/5/21 (016B21A) Moderna Dose 3 12/8/21 (939909) COVID Positive 12/15/21  12/15/21: -Patient is a 95 yo male from Nursing home with medical history of atrial fibrillation on anticoagulation , CKD stage 3, DMT2 with peripheral neuropathy , GERD, HTN, HLD, hypothyroidism , Dementia  -He was brought to the ER primarily because of bradycardia which is now resolved  -He also had cough and SOB and tested positive for COVID  -Patient is a poor historian because of underlying dementia  -His vitals on arrival no fever, HR 60s, RR 20s, BP 157/66 maintaining oxygen saturating on room air  -Lab remarkable for AKI Cr 1.28, elevated proBNP 7K, ALP 122, trop elevation 0.05 x 2, VBG ( PH 7.32, pCO2 55, pO2 35) , CBC unremarkable, urinalysis unremarkable, INR 2.0 influenza negative . EKG showed ventricular paced rhythm. Blood culture sent.  -CXR showed increased streaky opacity in right lung base could represent atelectasis versus infiltrate.  -Patient received Duoneb Tx , IV Ceftriaxone and Azithromycin IV lasix 40mg in the ER  -During encounter was impulsive, appears to be sundowning  12/20/21:  95-year-old male resident of a nursing home with dementia, atrial fibrillation anticoagulated on warfarin, permanent pacemaker, type 2 diabetes mellitus, hypertension presented with cough, shortness of breath and bradycardia.  Patient admitted for COVID-19 with superimposed bacterial pneumonia, sinus bradycardia which has resolved on arrival to the hospital.  Patient treated with antibiotics, IV dexamethasone and breathing treatments.  Due to his bradycardia remdesivir was not given.  Patient was briefly on oxygen subsequently weaned off to room air , shortness of breath and cough has improved.  Had an episode of a fall during the hospitalization with no sequelae, head CT was unremarkable for acute abnormalities.  Patient has supratherapeutic INR with no evidence of bleeding, was given vitamin K 2.5 mg p.o. x1 and warfarin was held on discharge.  INR will be checked in 2 days of discharge to be followed by patient's primary care provider.  PTOT evaluated patient and recommended returning to assisted living with VNA.  On discharge patient was a febrile and hemodynamically stable.  Patient the will be on Medrol Dosepak.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Gait inability, Mobility decreased, Unresponsive to stimuli
Clinical narrative: Un able to walk, unable to sit straight, very weak and not responsive. I call Doctor office I was told to take to Urgent care. I could not move her. I call emergency paramedic came. reassure me she was not having stroke or heart attack. She probably was having reaction to Booster shot. to let her rest. Next day she was able to walk
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Interchange of vaccine products, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed Breakthrough - 4/15/2022  1st Dose - J&J - 6/15/2021  2nd Dose - Moderna - 4/1/2022
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Pain, Productive cough
Clinical narrative: 04/20/2022, I started having a dry cough all day. 4/21, it turned into a productive cough. I had sinus congestion, headache, body aches and fever. Everything got worse. 4/22, I had a tele health visit. He sent me for COVID test which was positive. He sent me to have a Monoclonal Antibodies Infusion. Within 24 hours, I felt perfect for a couple of days. The next week I began having the same symptoms. 5/9/2022, I tested positive with a home COVID test. I then had a tele health with my APN on 5/11/22 and asked if I could have a monoclonal antibodies infusion again. I was not able to. So he prescribed Paxlovid and I was unable to fill the prescription before it was too late to work. I still have a cough and sinus congestion.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: 04/20/2022, I started having a dry cough all day. 4/21, it turned into a productive cough. I had sinus congestion, headache, body aches and fever. Everything got worse. 4/22, I had a tele health visit. He sent me for COVID test which was positive. He sent me to have a Monoclonal Antibodies Infusion. Within 24 hours, I felt perfect for a couple of days. The next week I began having the same symptoms. 5/9/2022, I tested positive with a home COVID test. I then had a tele health with my APN on 5/11/22 and asked if I could have a monoclonal antibodies infusion again. I was not able to. So he prescribed Paxlovid and I was unable to fill the prescription before it was too late to work. I still have a cough and sinus congestion.
Age: 40.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Angiogram pulmonary abnormal, Blood chloride decreased, Blood potassium decreased, Blood sodium decreased
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 12/18/21 (lot NA) COVID Positive 12/22/21  12/22/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for hypoxia.  Patient reports about 6 days ago she had her COVID-19 booster shot.  After that she started having generalized body ache, nausea, vomiting, diarrhea, abdomen pain, shortness of breath, fevers/chills and headache.  Today patient seen at the urgent care and was found to be hypoxic so she was sent to the ED.  at this time patient reports shortness of breath has improved and denies headache, chest pain, dizziness or dysuria.   In the ED temperature 102.2, heart rate 92, RR 16, the patient did desaturate to 89% room air was placed on 2 L nasal cannula, blood pressure 138/81.  Chest x-ray negative.  CT angio negative for PE but did show scattered viral pneumonitis.  Sodium 133, potassium 2.7, chloride 88, troponin negative, WBC 10, D-dimer 0.85, COVID antigen positive and negative influenza.  Patient received Tylenol, Rocephin, Decadron and potassium in the ED.  12/24/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for mild hypoxia secondary to COVID-19 infection and severe hypokalemia with a potassium 2.7. Patient was admitted and commenced on oxygen supplementation, potassium chloride, remdesivir, antibiotics in addition to other supportive treatment.  On re-evaluation this morning she is feeling much better. Electrolytes abnormality has resolved.  She had oxygen walk for home determination and does not require home O2. Patient may benefit from COVID 19 program.  She is discharged on pre-admission home medications.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chills, Diarrhoea, Dyspnoea
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 12/18/21 (lot NA) COVID Positive 12/22/21  12/22/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for hypoxia.  Patient reports about 6 days ago she had her COVID-19 booster shot.  After that she started having generalized body ache, nausea, vomiting, diarrhea, abdomen pain, shortness of breath, fevers/chills and headache.  Today patient seen at the urgent care and was found to be hypoxic so she was sent to the ED.  at this time patient reports shortness of breath has improved and denies headache, chest pain, dizziness or dysuria.   In the ED temperature 102.2, heart rate 92, RR 16, the patient did desaturate to 89% room air was placed on 2 L nasal cannula, blood pressure 138/81.  Chest x-ray negative.  CT angio negative for PE but did show scattered viral pneumonitis.  Sodium 133, potassium 2.7, chloride 88, troponin negative, WBC 10, D-dimer 0.85, COVID antigen positive and negative influenza.  Patient received Tylenol, Rocephin, Decadron and potassium in the ED.  12/24/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for mild hypoxia secondary to COVID-19 infection and severe hypokalemia with a potassium 2.7. Patient was admitted and commenced on oxygen supplementation, potassium chloride, remdesivir, antibiotics in addition to other supportive treatment.  On re-evaluation this morning she is feeling much better. Electrolytes abnormality has resolved.  She had oxygen walk for home determination and does not require home O2. Patient may benefit from COVID 19 program.  She is discharged on pre-admission home medications.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Electrolyte imbalance, Fibrin D dimer, Headache, Hypokalaemia, Hypoxia
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 12/18/21 (lot NA) COVID Positive 12/22/21  12/22/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for hypoxia.  Patient reports about 6 days ago she had her COVID-19 booster shot.  After that she started having generalized body ache, nausea, vomiting, diarrhea, abdomen pain, shortness of breath, fevers/chills and headache.  Today patient seen at the urgent care and was found to be hypoxic so she was sent to the ED.  at this time patient reports shortness of breath has improved and denies headache, chest pain, dizziness or dysuria.   In the ED temperature 102.2, heart rate 92, RR 16, the patient did desaturate to 89% room air was placed on 2 L nasal cannula, blood pressure 138/81.  Chest x-ray negative.  CT angio negative for PE but did show scattered viral pneumonitis.  Sodium 133, potassium 2.7, chloride 88, troponin negative, WBC 10, D-dimer 0.85, COVID antigen positive and negative influenza.  Patient received Tylenol, Rocephin, Decadron and potassium in the ED.  12/24/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for mild hypoxia secondary to COVID-19 infection and severe hypokalemia with a potassium 2.7. Patient was admitted and commenced on oxygen supplementation, potassium chloride, remdesivir, antibiotics in addition to other supportive treatment.  On re-evaluation this morning she is feeling much better. Electrolytes abnormality has resolved.  She had oxygen walk for home determination and does not require home O2. Patient may benefit from COVID 19 program.  She is discharged on pre-admission home medications.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza virus test negative, Nausea, Oxygen saturation decreased, Pain, Pneumonia viral
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 12/18/21 (lot NA) COVID Positive 12/22/21  12/22/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for hypoxia.  Patient reports about 6 days ago she had her COVID-19 booster shot.  After that she started having generalized body ache, nausea, vomiting, diarrhea, abdomen pain, shortness of breath, fevers/chills and headache.  Today patient seen at the urgent care and was found to be hypoxic so she was sent to the ED.  at this time patient reports shortness of breath has improved and denies headache, chest pain, dizziness or dysuria.   In the ED temperature 102.2, heart rate 92, RR 16, the patient did desaturate to 89% room air was placed on 2 L nasal cannula, blood pressure 138/81.  Chest x-ray negative.  CT angio negative for PE but did show scattered viral pneumonitis.  Sodium 133, potassium 2.7, chloride 88, troponin negative, WBC 10, D-dimer 0.85, COVID antigen positive and negative influenza.  Patient received Tylenol, Rocephin, Decadron and potassium in the ED.  12/24/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for mild hypoxia secondary to COVID-19 infection and severe hypokalemia with a potassium 2.7. Patient was admitted and commenced on oxygen supplementation, potassium chloride, remdesivir, antibiotics in addition to other supportive treatment.  On re-evaluation this morning she is feeling much better. Electrolytes abnormality has resolved.  She had oxygen walk for home determination and does not require home O2. Patient may benefit from COVID 19 program.  She is discharged on pre-admission home medications.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Troponin normal, Vaccine breakthrough infection, Vomiting
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 12/18/21 (lot NA) COVID Positive 12/22/21  12/22/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for hypoxia.  Patient reports about 6 days ago she had her COVID-19 booster shot.  After that she started having generalized body ache, nausea, vomiting, diarrhea, abdomen pain, shortness of breath, fevers/chills and headache.  Today patient seen at the urgent care and was found to be hypoxic so she was sent to the ED.  at this time patient reports shortness of breath has improved and denies headache, chest pain, dizziness or dysuria.   In the ED temperature 102.2, heart rate 92, RR 16, the patient did desaturate to 89% room air was placed on 2 L nasal cannula, blood pressure 138/81.  Chest x-ray negative.  CT angio negative for PE but did show scattered viral pneumonitis.  Sodium 133, potassium 2.7, chloride 88, troponin negative, WBC 10, D-dimer 0.85, COVID antigen positive and negative influenza.  Patient received Tylenol, Rocephin, Decadron and potassium in the ED.  12/24/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for mild hypoxia secondary to COVID-19 infection and severe hypokalemia with a potassium 2.7. Patient was admitted and commenced on oxygen supplementation, potassium chloride, remdesivir, antibiotics in addition to other supportive treatment.  On re-evaluation this morning she is feeling much better. Electrolytes abnormality has resolved.  She had oxygen walk for home determination and does not require home O2. Patient may benefit from COVID 19 program.  She is discharged on pre-admission home medications.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count normal
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 12/18/21 (lot NA) COVID Positive 12/22/21  12/22/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for hypoxia.  Patient reports about 6 days ago she had her COVID-19 booster shot.  After that she started having generalized body ache, nausea, vomiting, diarrhea, abdomen pain, shortness of breath, fevers/chills and headache.  Today patient seen at the urgent care and was found to be hypoxic so she was sent to the ED.  at this time patient reports shortness of breath has improved and denies headache, chest pain, dizziness or dysuria.   In the ED temperature 102.2, heart rate 92, RR 16, the patient did desaturate to 89% room air was placed on 2 L nasal cannula, blood pressure 138/81.  Chest x-ray negative.  CT angio negative for PE but did show scattered viral pneumonitis.  Sodium 133, potassium 2.7, chloride 88, troponin negative, WBC 10, D-dimer 0.85, COVID antigen positive and negative influenza.  Patient received Tylenol, Rocephin, Decadron and potassium in the ED.  12/24/21: The patient is a 54-year-old female with past medical history of hypertension, hyperlipidemia, anxiety, tobacco use was sent in from urgent care for mild hypoxia secondary to COVID-19 infection and severe hypokalemia with a potassium 2.7. Patient was admitted and commenced on oxygen supplementation, potassium chloride, remdesivir, antibiotics in addition to other supportive treatment.  On re-evaluation this morning she is feeling much better. Electrolytes abnormality has resolved.  She had oxygen walk for home determination and does not require home O2. Patient may benefit from COVID 19 program.  She is discharged on pre-admission home medications.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID, I saw my Dr. was given a prescription for Paxlovid.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: Breakthrough COVID Case: Initially, fatigue and runny nose. Then, sore throat and feverish without fever. Very sore throat. I started Paxlovid on Tuesday.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID Case: Initially, fatigue and runny nose. Then, sore throat and feverish without fever. Very sore throat. I started Paxlovid on Tuesday.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pain in extremity, Pyrexia
Clinical narrative: Fever as high as 103 for 36 hours.   Right arm sore for 24 hours.  Large swollen lymph node on R collarbone.  Painful for 48 hours, continues to be largely swollen.
Age: 65.0
Sex: F
Vaccine: COVID19, PNC20
Symptoms: Injection site erythema, Injection site swelling, Pain in extremity
Clinical narrative: Patient reported having sore arm, reddness, swelling at injection site and pain in arm.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Inappropriate schedule of product administration, Vomiting
Clinical narrative: Client given COVID booster at 4 months after 2nd dose instead of 5 months after 2nd dose. According to mother, client threw up last night and was feeling warm with no fever in the morning. Still felt well enough to go to school.
Age: 38.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscular weakness
Clinical narrative: Patient vaccinated without incident.  Wife of patient phoned pharmacy at approximately 10:00am this morning reporting that her husband (patient) was having numbness and weakness in both legs, not allowing him to bear weight.  Patient conscious and breathing normally.  I advised her to immediately call EMS for evaluation.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hypothermia
Clinical narrative: I ended up with hypothermia, it lasted until the next day. I was covered in blankets and my fiancé laid with me to keep me warm. By the next morning my temperature was back to normal.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalization with covid after being fully vaccinated and booster X2.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed Breakthrough Case 1st Dose 1/28/2021 Pfizer EL9261 2nd Dose 2/18/2021 Pfizer El9267 3rd Dose 10/7/021 Pfizer EW0164
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation
Clinical narrative: inflammation of neck and shoulders
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, COVID-19, Cough, Fatigue, Headache
Clinical narrative: Approximately 2 weeks after my 4th dose vaccination I contracted COVID-19 and had the following symptoms: Sore Throat, Body Aches, Fever, Headache, Cough, Fatigue and Lost of Taste. I took Tylenol every 6 hours and Robitussin every 8 hours and some cold compress. The medications helped ease my symptoms and as of today (05/17/2022) I am on the road to recovery and have been feeling better with minimal symptoms.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Approximately 2 weeks after my 4th dose vaccination I contracted COVID-19 and had the following symptoms: Sore Throat, Body Aches, Fever, Headache, Cough, Fatigue and Lost of Taste. I took Tylenol every 6 hours and Robitussin every 8 hours and some cold compress. The medications helped ease my symptoms and as of today (05/17/2022) I am on the road to recovery and have been feeling better with minimal symptoms.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Malaise, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I had a scratchy throat. I took an at home test that was negative. I was taking Mucinex and using a Netty Pot to deal with the symptoms. I still was not feeling well and I took another COVID test on Sunday and it was positive. I did not have a fever or lose my sense of taste or smell. I primarily have congestion in my chest. On Wednesday, I went to have the monoclonal antibody treatment. I am still suffering from congestion and fatigue. I had a telehealth appointment on Monday and the provider recommended that I get the antibodies which I got on Wednesday.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: I had a scratchy throat. I took an at home test that was negative. I was taking Mucinex and using a Netty Pot to deal with the symptoms. I still was not feeling well and I took another COVID test on Sunday and it was positive. I did not have a fever or lose my sense of taste or smell. I primarily have congestion in my chest. On Wednesday, I went to have the monoclonal antibody treatment. I am still suffering from congestion and fatigue. I had a telehealth appointment on Monday and the provider recommended that I get the antibodies which I got on Wednesday.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Product administered at inappropriate site
Clinical narrative: I experienced stiffeness in my left arm. It lasted for months and I still have remnants of it. I believe the shot was administered too high.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccines where not stored at correct temperature they had been store in freezer instead of refrigerator
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, Blood chloride increased, Blood creatinine increased, Blood glucose normal
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DNP, A-GNP Admission Date: 5/12/2022 Discharge Date: 5/14/2022  PRESENTING PROBLEM: Acute kidney injury due to COVID-19 (HCC) COVID-19      HPI: 85-year-old female with a history of hypertension, hyperlipidemia, previous CVA with left-sided weakness, chronic kidney disease stage 3. Patient presents to the emergency room with complaints of weakness for over a month.  Much worse over the last week.  Last night she had a cough which would not allow her to sleep, nonproductive.  She denies any fevers or chills.  No chest pain.  She does states she has been short of breath for the last week or 2, particularly with exertion.  Patient presented to the emergency room today as her cough was worsening.  On arrival she was hemodynamically stable, satting 97% on room air.  She was mildly ill appearing but pleasant and conversant.  Lungs show diminished breath sounds at the bases heart was regular rate and rhythm abdomen was benign.  Extremities showed 1+ edema with chronic venous stasis changes bilaterally. Sodium 138 potassium 5.1 chloride 110 CO2 16 BUN 72 creatinine 2.16 (baseline creatinine is around 1.3).  Glucose 152 liver enzymes normal complete blood count was normal.  Chest x-ray showed no acute disease. Patient has COVID-19 came back positive. Patient states she has had slight decreased oral intake over the last week.  She denies taking NSAIDs.  Patient also has a chronic ileostomy, history of Crohn's disease.  Currently not on medications.     HOSPITAL COURSE: Patient did well.  She was gently hydrated with IV fluids and her acute kidney injury continue to improve, creatinine now 1.4.  She was eating well, having reasonable urine output.  Vital signs have been stable.  She has been on room air oxygen throughout this admission, not showing any signs or symptoms of COVID-19 pneumonia.  Patient is stable for discharge.  On day of discharge she reports that she feels stronger today than she has in over a month.  Patient will continue with COVID 19 discharge instructions, also encourage good oral intake.  Patient to follow-up with primary care provider next week.  Patient does have a mild persistent metabolic acidosis, which can be followed up as outpatient with repeat BMP next week.  Patient advised to return should she develop any shortness of breath or any other problems
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Blood potassium increased, Blood sodium normal, Blood urea increased, Breath sounds abnormal, COVID-19
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DNP, A-GNP Admission Date: 5/12/2022 Discharge Date: 5/14/2022  PRESENTING PROBLEM: Acute kidney injury due to COVID-19 (HCC) COVID-19      HPI: 85-year-old female with a history of hypertension, hyperlipidemia, previous CVA with left-sided weakness, chronic kidney disease stage 3. Patient presents to the emergency room with complaints of weakness for over a month.  Much worse over the last week.  Last night she had a cough which would not allow her to sleep, nonproductive.  She denies any fevers or chills.  No chest pain.  She does states she has been short of breath for the last week or 2, particularly with exertion.  Patient presented to the emergency room today as her cough was worsening.  On arrival she was hemodynamically stable, satting 97% on room air.  She was mildly ill appearing but pleasant and conversant.  Lungs show diminished breath sounds at the bases heart was regular rate and rhythm abdomen was benign.  Extremities showed 1+ edema with chronic venous stasis changes bilaterally. Sodium 138 potassium 5.1 chloride 110 CO2 16 BUN 72 creatinine 2.16 (baseline creatinine is around 1.3).  Glucose 152 liver enzymes normal complete blood count was normal.  Chest x-ray showed no acute disease. Patient has COVID-19 came back positive. Patient states she has had slight decreased oral intake over the last week.  She denies taking NSAIDs.  Patient also has a chronic ileostomy, history of Crohn's disease.  Currently not on medications.     HOSPITAL COURSE: Patient did well.  She was gently hydrated with IV fluids and her acute kidney injury continue to improve, creatinine now 1.4.  She was eating well, having reasonable urine output.  Vital signs have been stable.  She has been on room air oxygen throughout this admission, not showing any signs or symptoms of COVID-19 pneumonia.  Patient is stable for discharge.  On day of discharge she reports that she feels stronger today than she has in over a month.  Patient will continue with COVID 19 discharge instructions, also encourage good oral intake.  Patient to follow-up with primary care provider next week.  Patient does have a mild persistent metabolic acidosis, which can be followed up as outpatient with repeat BMP next week.  Patient advised to return should she develop any shortness of breath or any other problems
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Carbon dioxide decreased, Chest X-ray normal, Cough, Dyspnoea, Dyspnoea exertional
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DNP, A-GNP Admission Date: 5/12/2022 Discharge Date: 5/14/2022  PRESENTING PROBLEM: Acute kidney injury due to COVID-19 (HCC) COVID-19      HPI: 85-year-old female with a history of hypertension, hyperlipidemia, previous CVA with left-sided weakness, chronic kidney disease stage 3. Patient presents to the emergency room with complaints of weakness for over a month.  Much worse over the last week.  Last night she had a cough which would not allow her to sleep, nonproductive.  She denies any fevers or chills.  No chest pain.  She does states she has been short of breath for the last week or 2, particularly with exertion.  Patient presented to the emergency room today as her cough was worsening.  On arrival she was hemodynamically stable, satting 97% on room air.  She was mildly ill appearing but pleasant and conversant.  Lungs show diminished breath sounds at the bases heart was regular rate and rhythm abdomen was benign.  Extremities showed 1+ edema with chronic venous stasis changes bilaterally. Sodium 138 potassium 5.1 chloride 110 CO2 16 BUN 72 creatinine 2.16 (baseline creatinine is around 1.3).  Glucose 152 liver enzymes normal complete blood count was normal.  Chest x-ray showed no acute disease. Patient has COVID-19 came back positive. Patient states she has had slight decreased oral intake over the last week.  She denies taking NSAIDs.  Patient also has a chronic ileostomy, history of Crohn's disease.  Currently not on medications.     HOSPITAL COURSE: Patient did well.  She was gently hydrated with IV fluids and her acute kidney injury continue to improve, creatinine now 1.4.  She was eating well, having reasonable urine output.  Vital signs have been stable.  She has been on room air oxygen throughout this admission, not showing any signs or symptoms of COVID-19 pneumonia.  Patient is stable for discharge.  On day of discharge she reports that she feels stronger today than she has in over a month.  Patient will continue with COVID 19 discharge instructions, also encourage good oral intake.  Patient to follow-up with primary care provider next week.  Patient does have a mild persistent metabolic acidosis, which can be followed up as outpatient with repeat BMP next week.  Patient advised to return should she develop any shortness of breath or any other problems
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count normal, General physical condition abnormal, Hepatic enzyme, Hypophagia, Metabolic acidosis
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DNP, A-GNP Admission Date: 5/12/2022 Discharge Date: 5/14/2022  PRESENTING PROBLEM: Acute kidney injury due to COVID-19 (HCC) COVID-19      HPI: 85-year-old female with a history of hypertension, hyperlipidemia, previous CVA with left-sided weakness, chronic kidney disease stage 3. Patient presents to the emergency room with complaints of weakness for over a month.  Much worse over the last week.  Last night she had a cough which would not allow her to sleep, nonproductive.  She denies any fevers or chills.  No chest pain.  She does states she has been short of breath for the last week or 2, particularly with exertion.  Patient presented to the emergency room today as her cough was worsening.  On arrival she was hemodynamically stable, satting 97% on room air.  She was mildly ill appearing but pleasant and conversant.  Lungs show diminished breath sounds at the bases heart was regular rate and rhythm abdomen was benign.  Extremities showed 1+ edema with chronic venous stasis changes bilaterally. Sodium 138 potassium 5.1 chloride 110 CO2 16 BUN 72 creatinine 2.16 (baseline creatinine is around 1.3).  Glucose 152 liver enzymes normal complete blood count was normal.  Chest x-ray showed no acute disease. Patient has COVID-19 came back positive. Patient states she has had slight decreased oral intake over the last week.  She denies taking NSAIDs.  Patient also has a chronic ileostomy, history of Crohn's disease.  Currently not on medications.     HOSPITAL COURSE: Patient did well.  She was gently hydrated with IV fluids and her acute kidney injury continue to improve, creatinine now 1.4.  She was eating well, having reasonable urine output.  Vital signs have been stable.  She has been on room air oxygen throughout this admission, not showing any signs or symptoms of COVID-19 pneumonia.  Patient is stable for discharge.  On day of discharge she reports that she feels stronger today than she has in over a month.  Patient will continue with COVID 19 discharge instructions, also encourage good oral intake.  Patient to follow-up with primary care provider next week.  Patient does have a mild persistent metabolic acidosis, which can be followed up as outpatient with repeat BMP next week.  Patient advised to return should she develop any shortness of breath or any other problems
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test, Oedema peripheral, Peripheral venous disease, SARS-CoV-2 test positive, Sleep disorder
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DNP, A-GNP Admission Date: 5/12/2022 Discharge Date: 5/14/2022  PRESENTING PROBLEM: Acute kidney injury due to COVID-19 (HCC) COVID-19      HPI: 85-year-old female with a history of hypertension, hyperlipidemia, previous CVA with left-sided weakness, chronic kidney disease stage 3. Patient presents to the emergency room with complaints of weakness for over a month.  Much worse over the last week.  Last night she had a cough which would not allow her to sleep, nonproductive.  She denies any fevers or chills.  No chest pain.  She does states she has been short of breath for the last week or 2, particularly with exertion.  Patient presented to the emergency room today as her cough was worsening.  On arrival she was hemodynamically stable, satting 97% on room air.  She was mildly ill appearing but pleasant and conversant.  Lungs show diminished breath sounds at the bases heart was regular rate and rhythm abdomen was benign.  Extremities showed 1+ edema with chronic venous stasis changes bilaterally. Sodium 138 potassium 5.1 chloride 110 CO2 16 BUN 72 creatinine 2.16 (baseline creatinine is around 1.3).  Glucose 152 liver enzymes normal complete blood count was normal.  Chest x-ray showed no acute disease. Patient has COVID-19 came back positive. Patient states she has had slight decreased oral intake over the last week.  She denies taking NSAIDs.  Patient also has a chronic ileostomy, history of Crohn's disease.  Currently not on medications.     HOSPITAL COURSE: Patient did well.  She was gently hydrated with IV fluids and her acute kidney injury continue to improve, creatinine now 1.4.  She was eating well, having reasonable urine output.  Vital signs have been stable.  She has been on room air oxygen throughout this admission, not showing any signs or symptoms of COVID-19 pneumonia.  Patient is stable for discharge.  On day of discharge she reports that she feels stronger today than she has in over a month.  Patient will continue with COVID 19 discharge instructions, also encourage good oral intake.  Patient to follow-up with primary care provider next week.  Patient does have a mild persistent metabolic acidosis, which can be followed up as outpatient with repeat BMP next week.  Patient advised to return should she develop any shortness of breath or any other problems
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test abnormal, Central nervous system function test normal, Feeling of body temperature change, Hypoaesthesia, Immunisation reaction
Clinical narrative: Beginning day after vaccine: constant numbness/tingling sensations and hot/cold sensations throughout legs from knee to feet, with intermingled pain; same sensations of pain and numbness throughout arms and torso but less constantly. These constant sensations lasted about 2 weeks (January 20-February 1, 2022). After that time the frequency of sensations slowly decreased but intensity of pain has increased. From February 1, 2022 to present: painful pinching sensations throughout body (on arms, legs, torso, feet, joints, head) which occur randomly and without warning; approximately 2-8 sensations/hour. Occasional numbness on various parts of body.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test abnormal, Neurological examination normal, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Beginning day after vaccine: constant numbness/tingling sensations and hot/cold sensations throughout legs from knee to feet, with intermingled pain; same sensations of pain and numbness throughout arms and torso but less constantly. These constant sensations lasted about 2 weeks (January 20-February 1, 2022). After that time the frequency of sensations slowly decreased but intensity of pain has increased. From February 1, 2022 to present: painful pinching sensations throughout body (on arms, legs, torso, feet, joints, head) which occur randomly and without warning; approximately 2-8 sensations/hour. Occasional numbness on various parts of body.